Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Quarterly results

Guardant Health, Inc. (GH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance Q2 revenue increased 26% year over year driven by clinical volume growth of 49%"
08/01/2023 8-K Quarterly results
06/15/2023 144 Form 144 - Report of proposed sale of securities:
05/25/2023 8-K Asset disposition
Docs: "Underwriting Agreement, among Guardant Health, Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Cowen and Company, LLC and SVB Securities LLC, as representatives of the several underwriters named therein",
"Opinion of Latham & Watkins LLP"
05/23/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Guardant Health Reports First Quarter 2023 Financial Results Q1 revenue increased 34% year over year driven by clinical volume growth of 45%"
05/09/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Guardant Health presents additional information from ECLIPSE study at 2023 Digestive Disease Week on the performance of Shield ™ blood test"
05/08/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Guardant Health Announces Additions to Leadership Team"
04/27/2023 ARS Form ARS - Annual Report to Security Holders:
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/10/2023 SC 13G/A FMR LLC reports a 8.7% stake in GUARDANT HEALTH INC
03/02/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Musa Tariq joins Guardant Health board of directors"
02/23/2023 10-K Annual Report for the period ended December 31, 2022
02/23/2023 8-K Quarterly results
Docs: "Guardant Health Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook Q4 clinical and biopharma volumes up 41% and 24% year over year"
02/14/2023 SC 13G/A VIKING GLOBAL INVESTORS LP reports a 4% stake in Guardant Health, Inc.
02/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 8.8% stake in Guardant Health Inc.
02/09/2023 SC 13G/A FMR LLC reports a 15% stake in GUARDANT HEALTH INC
02/03/2023 SC 13G BlackRock Inc. reports a 5.4% stake in GUARDANT HEALTH, INC.
01/09/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Guardant Health Announces Preliminary Fourth Quarter and Full Year 2022 Results Full year clinical and biopharma volumes up 42% and 40% year over year"
12/15/2022 8-K Quarterly results
12/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/03/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/03/2022 8-K Quarterly results
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
07/07/2022 8-K Quarterly results
06/21/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy